Displaying items by tag: department of radiation oncology

The UAB Cancer Center offers patients with advanced and rare cancer, including those with any stage of pancreatic and brain cancer, the opportunity to have no-cost tumor profiling, and patients may be matched with an appropriate clinical trial or recommend use of an FDA-approved drug.
UAB will bring proton therapy, one of the most technically advanced forms of cancer-killing radiation, to Alabama with the new Proton Therapy Center.
Donald Buchsbaum is the sixth UAB faculty member enrolled in the National Academy of Inventors.
The partnership will bring a highly effective and precise alternative to traditional radiation therapy for treating cancer and some noncancerous tumors, without many of the side effects that often accompany treatment.
The new internal medicine and pediatric clinic will feature an outpatient diagnostic center with a cutting-edge imaging facility and full ambulatory lab services, all on-site.
UAB researcher awarded first joint AACR- TNBC Foundation Career Development Award focused specifically on triple negative breast cancer.
Christopher Willey receives a crucial ACS research grant to further his novel work on the MARCKS protein in relation to brain cancer.
Researchers identify the strategy that highly aggressive brain tumor cells use to fuel their relentless expansion and reveal a fresh target for cancer therapy.

The Regional Oncology Active Research (ROAR) initiative of the Southeast Cancer Foundation supports radiation oncology research.

Eddy S. Yang, M.D., Ph.D., was named the inaugural holder of the ROAR Southeast Cancer Foundation Endowed Professorship

Discovery may broaden clinical applications for a class of drugs that show promise for the treatment of familial breast and ovarian cancer.

UAB researchers say the MARCKS protein may be a biomarker for brain tumors and hold potential for targeted therapy.
Page 3 of 4